SAFETY OF COMBINED PIRFENIDONE AND NINTEDANIB IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

被引：0
|
作者：
Flaherty, K. R. [1 ]
Fell, C. D. [2 ]
Huggins, J. T. [3 ]
Nunes, H. [4 ]
Sussman, R. [5 ]
Valenzuela, C. [6 ]
Petzinger, U. [7 ]
Stauffer, J. L. [8 ]
Gilberg, F. [9 ]
Bengus, M. [9 ]
Wijsenbeek, M. [10 ]
机构：
[1] Univ Michigan, Ann Arbor, MI USA
[2] Univ Calgary, Calgary, AB, Canada
[3] Med Univ South Carolina, Charleston, SC USA
[4] Hop Avicenne, Paris, France
[5] Atlantic Hlth Syst, Overlook Med Ctr, Summit, NJ USA
[6] Hosp Univ La Princesa, Inst Invest Princesa, Madrid, Spain
[7] Clinipace Accovion GmbH, Eschborn, Germany
[8] Genentech Inc, San Francisco, CA 94080 USA
[9] F Hoffman La Roche Ltd, Basel, Switzerland
[10] Erasmus Univ, Med Ctr, Rotterdam, Netherlands
来源：
THORAX | 2017年 / 72卷
关键词：
D O I：
10.1136/thoraxjnl-2017-210983.453
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
M31
引用
下载
收藏
页码：A253 / A254
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of combined use of pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Safety of Combined Pirfenidone and Nintedanib in Subgroups of Patients with Idiopathic Pulmonary Fibrosis (IPF)
    Flaherty, K.
    Fell, C. D.
    Huggins, J. T.
    Nunes, H.
    Sussman, R.
    Valenzuela, C.
    Petzinger, U.
    Stauffer, J. L.
    Gilberg, F.
    Bengus, M.
    Wijsenbeek, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [3] Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
    Ogura, Takashi
    Taniguchi, Hiroyuki
    Azuma, Arata
    Inoue, Yoshikazu
    Kondoh, Yasuhiro
    Hasegawa, Yoshinori
    Bando, Masashi
    Abe, Shinji
    Mochizuki, Yoshiro
    Chida, Kingo
    Klueglich, Matthias
    Fujimoto, Tsuyoshi
    Okazaki, Kotaro
    Tadayasu, Yusuke
    Sakamoto, Wataru
    Sugiyama, Yukihiko
    EUROPEAN RESPIRATORY JOURNAL, 2015, 45 (05) : 1382 - 1392
  • [4] Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis
    Flaherty, Kevin R.
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52 (02)
  • [5] Efficacy and safety of combination therapy with pirfenidone and nintedanib in patients with idiopathic pulmonary fibrosis
    Huh, Jin-Young
    Lee, Jae Ha
    Song, Jin Woo
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [6] Late Breaking Abstract - Safety of combined pirfenidone (PFD) and nintedanib (NIN) in patients with idiopathic pulmonary fibrosis (IPF)
    Flaherty, Kevin
    Fell, Charlene D.
    Huggins, J. Terrill
    Nunes, Hilario
    Sussman, Robert
    Valenzuela, Claudia
    Petzinger, Ute
    Stauffer, John. L.
    Gilberg, Frank
    Bengus, Monica
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [7] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, D.
    Jouneau, S.
    Bouzille, G.
    Polard, E.
    Osmont, M. N.
    Scailteux, L. M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2022, 36 : 77 - 78
  • [8] Pirfenidone and Nintedanib for Treatment of Idiopathic Pulmonary Fibrosis
    Sathiyamoorthy, Gayathri
    Sehgal, Sameep
    Ashton, Rendell W.
    SOUTHERN MEDICAL JOURNAL, 2017, 110 (06) : 393 - 398
  • [9] Real-world safety profiles of pirfenidone and nintedanib in idiopathic pulmonary fibrosis patients
    Fournier, Dorine
    Jouneau, Stephane
    Bouzille, Guillaume
    Polard, Elisabeth
    Osmont, Marie-Noëlle
    Scailteux, Lucie-Marie
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2022, 76
  • [10] Outcomes in Patients Receiving Nintedanib or Pirfenidone for Idiopathic Pulmonary Fibrosis
    Cottin, V.
    Spagnolo, P.
    Bonniaud, P.
    Nolin, M.
    Dalon, F.
    Kirchgassler, K.
    Chia, J.
    Kamath, T. V.
    Van Ganse, E.
    Belhassen, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
12345